Published in Am J Trop Med Hyg on July 01, 2003
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J (2012) 2.37
Malaria. CMAJ (2004) 2.13
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar J (2007) 1.69
Malaria in selected non-Amazonian countries of Latin America. Acta Trop (2011) 1.53
Prevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional data. Confl Health (2007) 1.48
Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon. Malar J (2010) 1.43
Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop (2011) 1.43
Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol (2004) 1.39
Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg (2010) 1.34
Plasmodium falciparum genetic diversity maintained and amplified over 5 years of a low transmission endemic in the Peruvian Amazon. Mol Biol Evol (2010) 1.33
Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon. Am J Trop Med Hyg (2006) 1.33
Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J (2012) 1.32
Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res (2010) 1.27
Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural Amazonia. PLoS Negl Trop Dis (2014) 1.27
Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study. PLoS One (2011) 1.26
A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS One (2007) 1.22
Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.21
Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis (2015) 1.19
Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol (2012) 1.17
Malaria diagnosis by a polymerase chain reaction-based assay using a pooling strategy. Am J Trop Med Hyg (2009) 1.15
Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children. Malar J (2010) 1.15
Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin Vaccine Immunol (2008) 1.07
High prevalence of asymptomatic malaria in south-eastern Bangladesh. Malar J (2014) 1.07
High prevalence of sub-microscopic infections in Colombia. Malar J (2015) 1.04
Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands. Malar J (2013) 1.01
Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun (2012) 0.99
Hyperendemic malaria transmission in areas of occupation-related travel in the Peruvian Amazon. Malar J (2013) 0.99
Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey. PLoS One (2015) 0.98
Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz (2011) 0.95
The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen. Malar J (2010) 0.94
Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon. Malar J (2014) 0.94
Absence of asymptomatic malaria infection in endemic area of bashagard district, hormozgan province, iran. Iran J Parasitol (2012) 0.93
Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malar J (2012) 0.91
Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg (2015) 0.89
High degree of Plasmodium vivax diversity in the Peruvian Amazon demonstrated by tandem repeat polymorphism analysis. Am J Trop Med Hyg (2012) 0.89
Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon. Am J Trop Med Hyg (2013) 0.88
Assessing the future threat from vivax malaria in the United Kingdom using two markedly different modelling approaches. Malar J (2010) 0.88
A systematic review of sub-microscopic Plasmodium vivax infection. Malar J (2015) 0.87
Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon. J Infect Dis (2014) 0.84
Relationship of regulatory T cells to Plasmodium falciparum malaria symptomatology in a hypoendemic region. Malar J (2014) 0.84
Epidemiology of Plasmodium vivax Malaria in Peru. Am J Trop Med Hyg (2016) 0.84
Modelling the potential of focal screening and treatment as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region. Parasit Vectors (2015) 0.82
Elimination therapy for the endemic malarias. Curr Infect Dis Rep (2012) 0.82
Population Genetics of Plasmodium vivax in the Peruvian Amazon. PLoS Negl Trop Dis (2016) 0.80
Selective intermittent preventive treatment of vivax malaria: reduction of malaria incidence in an open cohort study in brazilian Amazon. Malar Res Treat (2013) 0.79
A comprehensive assessment of the malaria microscopy system of Aceh, Indonesia, in preparation for malaria elimination. Malar J (2015) 0.78
Lack of molecular correlates of Plasmodium vivax ookinete development. Am J Trop Med Hyg (2011) 0.78
Detection of human leptospirosis as a cause of acute fever by capture ELISA using a Leptospira interrogans serovar Copenhageni (M20) derived antigen. BMC Infect Dis (2013) 0.77
Micro-epidemiology and spatial heterogeneity of P. vivax parasitaemia in riverine communities of the Peruvian Amazon: A multilevel analysis. Sci Rep (2017) 0.76
Asymptomatic malaria, growth status, and anaemia among children in Lao People's Democratic Republic: a cross-sectional study. Malar J (2016) 0.75
A validated agent-based model to study the spatial and temporal heterogeneities of malaria incidence in the rainforest environment. Malar J (2015) 0.75
Micro-heterogeneity of malaria transmission in the Peruvian Amazon: a baseline assessment underlying a population-based cohort study. Malar J (2017) 0.75
Absence of Asymptomatic Malaria Infection in a Cross-sectional Study in Iranshahr District, Iran under Elimination Programmes. Iran J Parasitol (2017) 0.75
Predominance of asymptomatic and sub-microscopic infections characterizes the Plasmodium gametocyte reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2017) 0.75
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis (2002) 5.75
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
Human brucellosis. Lancet Infect Dis (2007) 4.92
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (2009) 4.81
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69
Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64
Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis (2008) 2.61
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Species identification after treatment for human taeniasis. Lancet (2004) 2.43
Syndromic surveillance: adapting innovations to developing settings. PLoS Med (2008) 2.38
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr (2009) 2.32
The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28
Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis (2012) 2.23
Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
How sexually dimorphic are we? Review and synthesis. Am J Hum Biol (2000) 2.07
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05
Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01
The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences. Palliat Med (2013) 2.00
Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78
Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci U S A (2010) 1.74
Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics (2006) 1.74
Fecal contamination of drinking water within peri-urban households, Lima, Peru. Am J Trop Med Hyg (2007) 1.72
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. Ann Am Thorac Soc (2014) 1.70
Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65
Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64
Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg (2008) 1.62
Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One (2008) 1.61
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis (2004) 1.60
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart (2011) 1.60
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis (2010) 1.60
Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. Lancet (2005) 1.57
Hyperendemic human and porcine Taenia solium infection in Perú. Am J Trop Med Hyg (2003) 1.56
Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis (2002) 1.56
Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55
Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54
The epidemiology of herpes simplex virus type 2 infection in low-income urban populations in coastal Peru. Sex Transm Dis (2005) 1.54
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53
Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg (2009) 1.53
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol (2012) 1.52
Helicobacter Pylori's plasticity zones are novel transposable elements. PLoS One (2009) 1.48
Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One (2010) 1.48
The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord (2009) 1.46
Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis (2010) 1.46
Case report: severe, symptomatic hypomagnesemia in acute leptospirosis. Am J Trop Med Hyg (2008) 1.45
Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res (2014) 1.44
Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission. J Biol Chem (2004) 1.44
Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg Infect Dis (2002) 1.43